Merck (MRK) earnings Q4 2025

Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products.  But the company posted a modest 2026 outlook that fell short of Wall Street’s expectations as it prepares for a few drugs to lose patent protection later this year and face generic…

Read More

The 7-year itch is real – But now it’s hitting in just 3 years: What changed about modern love?

Meet *Kanupriya, a 32-year-old marketing professional who is stepping up the corporate ladder. While her professional life is flourishing, she is growing her personal life from scratch– one connection at a time. Kanupriya married her colleague from a previous company after dating for a few months, but within the first two years of their marriage,…

Read More